Wed.Jun 14, 2023

article thumbnail

340B program reaches $100 billion in sales, while patients are left behind

PhRMA

The 340B Drug Pricing Program has grown yet again , exceeding $100 billion in sales in 2022 when 340B-priced medicines are measured at wholesale acquisition cost. Recent data from IQVIA shows 340B grew 12.2% year-over-year in 2022, continuing a trend in which 340B sales have almost doubled since 2018, outpacing growth of the total U.S. drug market.

261
261
article thumbnail

How Has Independent Pharmacy Evolved, and Where is it Heading Next?

Drug Topics

Drug Topics spoke to father and son pharmacist duo Grant and Austin Brown for a conversation about the evolution of the practice, the importance of holding elected officials accountable, and more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Creative Minds Make for Great Pharmacists

Pharmacy Is Right For Me

When it comes to pursuing a career in pharmacy, some may assume that it’s exclusively suited for those who have a strong scientific and mathematical background and analytical personality. However, this couldn’t be further from the truth. In fact, creative individuals can also find fulfilling careers in pharmacy, and here are a few reasons why.

article thumbnail

The Pharmacogenomics Data Are In So Why Is Adoption Still Lagging?

Pharmacy Times

Pharmacogenomics is gaining support in mental health and polypharmacy, where the data make a strong case for improvements in clinical and economic outcomes.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Sanofi goes 'all in' on AI with new app to support company's manufacturing, R&D and more

Fierce Pharma

Sanofi is jumping on the artificial intelligence boat with a new app and a pledge to become “the first pharma company powered by artificial intelligence at scale.” | Sanofi's new app, plai, provides teams with a “360° view" to aid decision-making. The platform is one step in the company's digital transformation and goal to become the "first pharma powered by AI at scale.

129
129
article thumbnail

In-Person Visits for Patients with Hematologic Neoplasms Decreased During Early Stages of COVID-19 Pandemic

Pharmacy Times

In-person visits to receive oral therapy, outpatient infusions, and inpatient infusion for the treatment of hematologic neoplasms declined in the early months of the COVID-19 pandemic, while telemedicine use increased slightly in the same period but remained low overall.

123
123

More Trending

article thumbnail

The Importance Of Community When Running A Rural Pharmacy

Drug Topics

Greg Mitchell joined Drug Topics to talk about the importance of community when you are a rural pharmacy, what challenges he's faced, and the power of joining a cooperative.

98
article thumbnail

Digital health should brace for 'significant amount of churn' as hospitals reconsider COVID-era tech contracts

Fierce Healthcare

Digital health companies should brace for a shake-up as COVID-era contracts inked with hospitals will soon be up for renewal, according to the results of a recent survey. | Numerous digital health contracts signed by hospitals reacting to COVID-19 are nearing their conclusion, giving many providers a chance to reevaluate their options, a recent executive survey suggests.

Hospitals 127
article thumbnail

Nirsevimab Recommended by FDA Advisory Committee to Protect Infants Against RSV

Drug Topics

The FDA’s Antimicrobial Drugs Advisory Committee decided to recommend nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.

FDA 98
article thumbnail

With FTC eyeing biopharma M&A deals, Pfizer refiles paperwork for $43B buyout of Seagen

Fierce Pharma

An FTC lawsuit aimed at blocking Amgen’s $27.8 billion buyout o | An FTC lawsuit aimed at blocking Amgen’s $27.8 billion buyout of Horizon Therapeutics has raised concerns that the United States’ antitrust watchdog is tightening the screws on major M&A moves in the biopharma industry. A month later, according to an SEC filing, Pfizer has withdrawn its notification for its proposed $43 billion acquisition of cancer drug specialist Seagen and will submit another later in the day.

118
118
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Health spending growth slowed in 2022. That trend's set to change, experts say

Fierce Healthcare

While national health spending growth slowed in 2022, that trend isn't likely to stick around. | While national health spending growth slowed in 2022, that trend isn't likely to stick around, actuaries at CMS said Wednesday.

118
118
article thumbnail

Bacterial infection may be ‘key event’ in common but mysterious endometriosis, study says

STAT

Endometriosis, a common gynecological condition, is one of health’s great mimickers. It can manifest as a variety of painful symptoms but evade detection on scans and examinations. And for the estimated 10% to 15% of women with endometriosis, it can take over a decade to get a diagnosis. Part of the lag is because researchers still don’t know exactly how endometriosis occurs, except that the flow of menstrual blood backward through the fallopian tubes plays a role in some cases.

111
111
article thumbnail

UnitedHealth's stock declines as it predicts increase in medical costs for Q2

Fierce Healthcare

Insurance giant UnitedHealth Group's stock was down Wednesday after executives warned that higher medical costs are likely for the second quarter. | Insurance giant UnitedHealth Group's stock was down on Wednesday after executives warned that higher medical costs are likely for the second quarter.

Insurance 118
article thumbnail

STAT+: Muzzled for years, vindicated MIT professor says fraud investigation into his lab did lasting damage

STAT

For three years, nine months, and one week, Ram Sasisekharan lived under a gag order. In 2019, some of the Massachusetts Institute of Technology professor’s peers publicly accused his lab of falsifying research, setting in motion a lengthy internal investigation that sidelined his work, decimated his team, and barred him from speaking out in his own defense.

105
105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Oracle Q4 revenue up 18%, boosted by Cerner acquisition and strength in cloud businesses

Fierce Healthcare

Cerner brought in $1.5 billion in revenue in the latest quarter, boosting strong growth for enterprise software giant Oracle. | Cerner brought in $1.5 billion in revenue in the latest quarter, boosting strong growth for enterprise software giant Oracle. But hospital CIOs who use Cerner continue to have reservations about the future of the EHR company, citing the lack of a concrete road map.

Cerner 115
article thumbnail

Smoking Cessation Watch

Pharmacy Times

There are a multitude of benefits to smoking cessation, along with novel resources to make cessation more manageable.

121
121
article thumbnail

Behavioral health provider Two Chairs debuts clinician dashboard to support measurement-based care

Fierce Healthcare

Two Chairs, a hybrid behavioral health provider, launched a customized clinician dashboard for delivering measurement-based care. | The therapist-facing platform analyzes patient data with the goal of enabling therapists to quickly adjust treatment plans and improve outcomes.

110
110
article thumbnail

Social Norms Theory-Based Interventions Can Improve Health Care Workers Attitudes Toward Patients With HIV, People Who Inject Drugs

Pharmacy Times

Social norms appear to influence individual behavior more than personal attitudes among people living with HIV.

123
123
article thumbnail

From AI oversight to noncompete contracts, these issues were top of mind for physician leaders at AMA's policy meeting

Fierce Healthcare

The country’s largest physician organization is taking a strong stance against noncompete contracts for physicians and is redoubling efforts to urge Congress to boost Medicare payments. | The country’s largest physician organization is taking a strong stance against noncompete contracts for physicians and is redoubling efforts to urge Congress to boost Medicare payments.

110
110
article thumbnail

STAT+: Health insurance stocks tumble after UnitedHealth says Medicare enrollees are getting more care

STAT

A top executive at UnitedHealth Group said Tuesday that the health insurance and services conglomerate has noticed “a meaningfully higher number” of outpatient visits among Medicare patients in the second quarter of this year. The trend indicates a lot of older adults are getting care they had previously put off, which would eat into insurers’ earnings.

Insurance 100
article thumbnail

Lawsuit accuses Harvard Pilgrim of 'negligently failing' to protect members' data following breach

Fierce Healthcare

Harvard Pilgrim Health Care and its parent company, Point32Health, have been hit with a class-action lawsuit for allegedly failing to secure the personal information of over 2.5 million people. | Harvard Pilgrim Health Care and its parent company, Point32Health, have been hit with a class action lawsuit for allegedly failing to secure the personal information of over 2.5 million people.

109
109
article thumbnail

Opinion: Medicaid adult dental benefits are shamefully — and dangerously — inadequate in most states

STAT

In the middle of the night, you’re jolted awake by a throbbing pain in your mouth that is radiating down your neck and behind your eyes. Earlier in the week, it was just a small toothache, but now over-the-counter remedies can’t even begin to address the excruciating pain. Knowing you will not be able to get any sleep tonight, let alone concentrate on work tomorrow, you head to the emergency room, where they suspect you have an infection inside of your tooth or an abscess.

100
100
article thumbnail

Embracing the 60-Plus Economy

Pharmaceutical Commerce

In this latest Harvard Business School Healthcare Alumni Association Q&A, Susan Wilner Golden, DSC, lecturer at the Stanford Graduate School of Business, reveals an untapped $22 trillion global opportunity for all companies and others supporting healthy aging and longer life spans.

98
article thumbnail

ASCO 2023 – Corina Dutcus

pharmaphorum

At ASCO 2023 last week in Chicago, Editor in Chief Jonah Comstock caught up with Dr Corina Dutcus, SVP clinical development at Eisai US, to talk about the CLEAR trial, one of Eisai’s major abstracts being presented at the show.

98
article thumbnail

Opinion: Listen: Physicians have a moral and professional obligation to get into ‘good trouble’

STAT

Just days after the end of Roe v. Wade, Caitlin Bernard, an OB-GYN in Indiana, told the Indianapolis Star a heartbreaking story: She had recently been asked to perform an abortion on a 10-year-old Ohio girl who had been raped. The end of Roe had ushered in a six-week abortion ban in Ohio, and the girl was just past that mark in her pregnancy, meaning she could not access care in her own state.

98
article thumbnail

Does emerging evidence suggest medical cannabis has cardiovascular risks?

Hospital Pharmacy Europe

With increasing evidence that cannabis use is associated with adverse cardiovascular effects, questions are undoubtedly being asked about the safety of the drug for medical uses. Rod Tucker investigates. Cannabis was one of the first plants cultivated by man, and its first use can be traced to ancient China where evidence suggests it was used for medical purposes from around 2,700 BC and for textiles and other uses as early as 4,000 BC.

article thumbnail

STAT+: Pharmalittle: A not-so-new Biogen?; ALS Association and 15 chapters part ways over organizational clashes

STAT

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today boasts the aroma of pumpkins — and get started. To help you along, we have assembled another menu of tidbits for you to peruse.

98
article thumbnail

US FDA grants fast track status for CellCentric’s inobrodib

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted fast track designation for CellCentric’s inobrodib (CCS1477) to treat relapsed or refractory multiple myeloma patients. Inobrodib is an oral first-in-class cancer drug, indicated for patients who have previously received four or more lines of therapy, including an anti-CD38 monoclonal antibody, an immunomodulatory agent and a proteasome inhibitor.

FDA 97
article thumbnail

STAT+: Federal advisory group rejects proposal to make medical device tracking easier

STAT

Every medical device has its own unique code, allowing manufacturers to keep track of their products once they enter the market. But while these codes are critical for recalling faulty devices or issuing updates, they rarely make their way into health records. For years, experts have argued for a simple fix: adding device identifiers to insurance claims forms, which doctors use to request reimbursement for medical services.

article thumbnail

CVS Health finalizes previously announced global opioid settlement agreement

Drug Store News

This settlement will resolve opioid-related claims and litigation by states, territories and political subdivisions such as counties and cities in the United States.

98
article thumbnail

USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ Disease

Pharmacy Times

Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.

121
121
article thumbnail

Inside Beauty: Soapbox co-founder and CEO discusses the personalization of hair care

Drug Store News

David Simnick, co-founder and CEO of Soapbox, shares how the beauty industry embraces all kinds of hair types and why consumers seek personalized ingredients for their tresses.

94
article thumbnail

Pharma1 | Mastering the First Impression

PioneerRx

Pharma1 Pharmacy & Wellness Center in McKinney, TX is not your average pharmacy. As soon as you step through the door, you get a relaxed, spa-like feel from.

98
article thumbnail

Sun Pharma approves appointment of 2 board directors

Drug Store News

Sun Pharma's board of directors recently approved the appointment of Rolf Hoffmann and Aalok Shanghvi to its board.

105
105